company background image
PNV logo

PolyNovo ASX:PNV Rapport sur les actions

Dernier prix

AU$2.04

Capitalisation boursière

AU$1.4b

7D

1.5%

1Y

52.2%

Mise à jour

25 Nov, 2024

Données

Finances de l'entreprise +

PolyNovo Limited

ASX:PNV Rapport sur les actions

Capitalisation boursière : AU$1.4b

PNV Aperçu des actions

PolyNovo Limited conçoit, fabrique et vend des dispositifs médicaux biodégradables aux États-Unis, en Australie, en Nouvelle-Zélande et dans le monde entier. Plus de détails

PNV analyse fondamentale
Score flocon de neige
Évaluation2/6
Croissance future5/6
Performances passées3/6
Santé financière5/6
Dividendes0/6

PolyNovo Limited Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour PolyNovo
Historique des cours de bourse
Prix actuel de l'actionAU$2.04
Plus haut sur 52 semainesAU$2.78
Plus bas sur 52 semainesAU$1.34
Bêta1.72
1Variation sur 1 mois-5.12%
Variation sur 3 mois-17.07%
Variation sur 1 an52.24%
3Variation sur 3 ans40.21%
Variation sur 5 ans11.78%
Évolution depuis l'introduction en bourse920.00%

Nouvelles et mises à jour récentes

Is It Time To Consider Buying PolyNovo Limited (ASX:PNV)?

Oct 10
Is It Time To Consider Buying PolyNovo Limited (ASX:PNV)?

Recent updates

Is It Time To Consider Buying PolyNovo Limited (ASX:PNV)?

Oct 10
Is It Time To Consider Buying PolyNovo Limited (ASX:PNV)?

PolyNovo (ASX:PNV) Is Experiencing Growth In Returns On Capital

Aug 28
PolyNovo (ASX:PNV) Is Experiencing Growth In Returns On Capital

PolyNovo Limited's (ASX:PNV) P/S Is On The Mark

Aug 06
PolyNovo Limited's (ASX:PNV) P/S Is On The Mark

PolyNovo Limited's (ASX:PNV) P/S Is On The Mark

May 08
PolyNovo Limited's (ASX:PNV) P/S Is On The Mark

When Should You Buy PolyNovo Limited (ASX:PNV)?

Feb 28
When Should You Buy PolyNovo Limited (ASX:PNV)?

Why Investors Shouldn't Be Surprised By PolyNovo Limited's (ASX:PNV) P/S

Feb 02
Why Investors Shouldn't Be Surprised By PolyNovo Limited's (ASX:PNV) P/S

PolyNovo Limited (ASX:PNV) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jan 08
PolyNovo Limited (ASX:PNV) Shares Could Be 47% Below Their Intrinsic Value Estimate

Health Check: How Prudently Does PolyNovo (ASX:PNV) Use Debt?

Sep 22
Health Check: How Prudently Does PolyNovo (ASX:PNV) Use Debt?

When Should You Buy PolyNovo Limited (ASX:PNV)?

Jun 26
When Should You Buy PolyNovo Limited (ASX:PNV)?

Are Investors Undervaluing PolyNovo Limited (ASX:PNV) By 29%?

May 30
Are Investors Undervaluing PolyNovo Limited (ASX:PNV) By 29%?

Shareholders Should Be Pleased With PolyNovo Limited's (ASX:PNV) Price

Apr 18
Shareholders Should Be Pleased With PolyNovo Limited's (ASX:PNV) Price

Is It Too Late To Consider Buying PolyNovo Limited (ASX:PNV)?

Mar 23
Is It Too Late To Consider Buying PolyNovo Limited (ASX:PNV)?

Is PolyNovo Limited (ASX:PNV) Worth AU$2.6 Based On Its Intrinsic Value?

Feb 05
Is PolyNovo Limited (ASX:PNV) Worth AU$2.6 Based On Its Intrinsic Value?

Returns At PolyNovo (ASX:PNV) Are On The Way Up

Nov 16
Returns At PolyNovo (ASX:PNV) Are On The Way Up

PolyNovo Limited's (ASX:PNV) Intrinsic Value Is Potentially 95% Above Its Share Price

Nov 01
PolyNovo Limited's (ASX:PNV) Intrinsic Value Is Potentially 95% Above Its Share Price

What Does PolyNovo Limited's (ASX:PNV) Share Price Indicate?

Jul 29
What Does PolyNovo Limited's (ASX:PNV) Share Price Indicate?

PolyNovo (ASX:PNV) Is Looking To Continue Growing Its Returns On Capital

Jun 15
PolyNovo (ASX:PNV) Is Looking To Continue Growing Its Returns On Capital

Estimating The Fair Value Of PolyNovo Limited (ASX:PNV)

May 16
Estimating The Fair Value Of PolyNovo Limited (ASX:PNV)

We Think PolyNovo (ASX:PNV) Is Taking Some Risk With Its Debt

Apr 28
We Think PolyNovo (ASX:PNV) Is Taking Some Risk With Its Debt

There's Been No Shortage Of Growth Recently For PolyNovo's (ASX:PNV) Returns On Capital

Mar 07
There's Been No Shortage Of Growth Recently For PolyNovo's (ASX:PNV) Returns On Capital

Is PolyNovo (ASX:PNV) Weighed On By Its Debt Load?

Dec 13
Is PolyNovo (ASX:PNV) Weighed On By Its Debt Load?

PolyNovo Limited's (ASX:PNV) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 19
PolyNovo Limited's (ASX:PNV) CEO Compensation Looks Acceptable To Us And Here's Why

Is PolyNovo (ASX:PNV) Using Debt In A Risky Way?

May 08
Is PolyNovo (ASX:PNV) Using Debt In A Risky Way?

News Flash: 7 Analysts Think PolyNovo Limited (ASX:PNV) Earnings Are Under Threat

Feb 27
News Flash: 7 Analysts Think PolyNovo Limited (ASX:PNV) Earnings Are Under Threat

Earnings Update: PolyNovo Limited (ASX:PNV) Just Reported And Analysts Are Trimming Their Forecasts

Feb 25
Earnings Update: PolyNovo Limited (ASX:PNV) Just Reported And Analysts Are Trimming Their Forecasts

Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?

Feb 17
Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?

Rendement pour les actionnaires

PNVAU Medical EquipmentAU Marché
7D1.5%0.5%0.9%
1Y52.2%14.8%18.4%

Rendement vs Industrie: PNV a dépassé le secteur Australian Medical Equipment qui a rapporté 14.8 % au cours de l'année écoulée.

Rendement vs marché: PNV a dépassé le marché Australian qui a rapporté 18.4 % au cours de l'année écoulée.

Volatilité des prix

Is PNV's price volatile compared to industry and market?
PNV volatility
PNV Average Weekly Movement5.7%
Medical Equipment Industry Average Movement9.4%
Market Average Movement8.5%
10% most volatile stocks in AU Market17.5%
10% least volatile stocks in AU Market3.2%

Cours de l'action stable: PNV n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de PNV ( 6% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
1998254Swami Raotepolynovo.com

PolyNovo Limited conçoit, fabrique et vend des dispositifs médicaux biodégradables aux États-Unis, en Australie, en Nouvelle-Zélande et dans le monde entier. L'entreprise propose la matrice temporisante biodégradable NovoSorb, un échafaudage dermique pour la régénération du derme en cas de perte à la suite d'une intervention chirurgicale importante, d'un traumatisme ou d'une brûlure. Elle développe également des dispositifs herniaires pour la réparation des hernies et des solutions pour les hernies ventrales et la reconstruction complexe de la paroi abdominale ; NovoSorb Dermal Beta Cell, un nouveau pancréas ectopique intracutané pour traiter le diabète de type 1 ; NovoSorb MTX pour la greffe en une seule étape dans les brûlures, les plaies chroniques et chirurgicales ; et des produits de plastique et de dispositifs reconstructifs.

PolyNovo Limited Résumé des fondamentaux

Comment les bénéfices et les revenus de PolyNovo se comparent-ils à sa capitalisation boursière ?
PNV statistiques fondamentales
Capitalisation boursièreAU$1.37b
Bénéfices(TTM)AU$5.26m
Recettes(TTM)AU$103.23m

267.8x

Ratio P/E

13.7x

Ratio P/S

Le site PNV est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
PNV compte de résultat (TTM)
RecettesAU$103.23m
Coût des recettesAU$16.41m
Marge bruteAU$86.82m
Autres dépensesAU$81.56m
Les revenusAU$5.26m

Derniers bénéfices déclarés

Jun 30, 2024

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)0.0076
Marge brute84.11%
Marge bénéficiaire nette5.10%
Ratio dettes/capitaux propres3.6%

Quelles ont été les performances à long terme de PNV?

Voir les performances historiques et les comparaisons